Healthcare Vertical SaaS
Cloud EHR, scheduling, billing and revenue-cycle-management platform serving 84 clinic groups (~310 locations, 22 specialties, 67 employees). $12.0M LTM revenue, $11.3M ARR, $2.4M EBITDA (20% margin), 108% NRR, 91% GRR and 5.8-year average customer tenure.
Full acquisition underwriting for a prospective buyer at a proposed $14.4M purchase price (6.0x EBITDA), evaluated against a 13.9x comparable-transaction median.
Investment case anchored on a mission-critical clinical workflow, high switching costs, recurring revenue and founder-succession-driven deal availability, with a path to expand EBITDA margin from 20% toward ~29%. Modeled an AI documentation add-on worth ~$3.1M incremental ARR at ~80% gross margin.
Recommendation: Pursue. 43% modeled gross IRR and 6.0x MoM under the base case.
Concise summary of the investment thesis, SaaS retention economics, valuation and modeled returns.
View Executive Summary →Detailed acquisition underwriting covering SaaS KPIs, quality of earnings, transaction structure, operating forecasts, sensitivities and value creation.
Leverage Strategic is led by Prashant Gupta, CA, MBA, bringing 10+ years of experience across transaction advisory, M&A, corporate strategy and investor relations. About Prashant → | LinkedIn →